AlbuRx (CSL Behring AG)


Welcome to the PulseAid listing for the AlbuRx drug offered from CSL Behring AG. This Human Serum Albumin [EPC],Increased Intravascular Volume [PE],Increased Oncotic Pressure [PE],Osmotic Activity [MoA],Serum Albumin [Chemical/Ingredient] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.

LABELER NAME / MANUFACTURER: CSL Behring AG
NON-PROPRIETARY NAME: ALBUMIN (HUMAN)
SUBSTANCE NAME: ALBUMIN HUMAN
TYPE: PLASMA DERIVATIVE
PHARMA CLASS: Human Serum Albumin [EPC],Increased Intravascular Volume [PE],Increased Oncotic Pressure [PE],Osmotic Activity [MoA],Serum Albumin [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2009-01-06
END MARKETING DATE: 0000-00-00


AlbuRx PLASMA DERIVATIVE Details:

Item DescriptionAlbuRx from CSL Behring AG
LABELER NAME: CSL Behring AG
DEA SCHEDULE:
ACTIVE STRENGTH: 12.5(g/50mL)
START MARKETING DATE: 2009-01-06
END MARKETING DATE: 0000-00-00
PRODUCT ID: 44206-251_5cdacd60-e24e-4406-bbbf-05710a251c52
PRODUCT NDC: 44206-251
APPLICATION NUMBER: BLA102366

Other ALBUMIN HUMAN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Baxalta US Inc.Buminate
CSL Behring AGAlbuRx
GRIFOLS USA, LLCALBUTEIN
KEDRION BIOPHARMA, INC.Albuked